Scott M. Coiante - Oct 3, 2023 Form 4 Insider Report for AGILE THERAPEUTICS INC (AGRX)

Role
Chief Financial Officer
Signature
/s/ Geoffrey P. Gilmore Attorney-in-Fact
Stock symbol
AGRX
Transactions as of
Oct 3, 2023
Transactions value $
$0
Form type
4
Date filed
10/4/2023, 04:45 PM
Previous filing
Aug 25, 2023
Next filing
Aug 26, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGRX Common Stock Award $0 +20K +25000% $0.00 20.1K Oct 3, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares represent restricted stock units ("RSUs") which were granted as an inducement grant to a new hire on October 3, 2023. The RSUs will vest in four equal installments over four years with the first installment vesting on August 16, 2024 and with the RSUs being fully vested on August 16, 2027.